COMBINATORX
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
COMBINATORX
Industry:
Biotechnology Health Care
Founded:
2000-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
70 M USD
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Investors List
Boston Millennia Partners
Boston Millennia Partners investment in Series C - CombinatoRx
Global Life Science Ventures
Global Life Science Ventures investment in Series C - CombinatoRx
Flagship Pioneering
Flagship Pioneering investment in Series C - CombinatoRx
TL Ventures
TL Ventures investment in Series C - CombinatoRx
Canaan Partners
Canaan Partners investment in Series C - CombinatoRx
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series C - CombinatoRx
Flagship Pioneering
Flagship Pioneering investment in Series B - CombinatoRx